Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up Following Better-Than-Expected Earnings

Phibro Animal Health Co. (NASDAQ:PAHC)’s share price gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $22.37, but opened at $23.88. Phibro Animal Health shares last traded at $23.97, with a volume of 29,625 shares.

The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PAHC. Barclays raised their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, January 29th. Finally, Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.50.

Institutional Trading of Phibro Animal Health

A number of institutional investors have recently made changes to their positions in PAHC. Algert Global LLC purchased a new stake in Phibro Animal Health in the second quarter worth approximately $193,000. Truist Financial Corp bought a new position in shares of Phibro Animal Health during the 2nd quarter valued at $308,000. Sanctuary Advisors LLC purchased a new position in shares of Phibro Animal Health in the 2nd quarter worth $481,000. SG Americas Securities LLC bought a new stake in shares of Phibro Animal Health in the third quarter worth $276,000. Finally, CWM LLC increased its position in Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after acquiring an additional 4,175 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

The business has a fifty day simple moving average of $21.89 and a two-hundred day simple moving average of $21.60. The company has a market cap of $961.88 million, a P/E ratio of 55.44, a P/E/G ratio of 0.56 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.